日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular imaging of fibroblast activation in systemic sclerosis using [(18)F]AlF-NOTA-FAPI-04 PET/CT: a prospective cohort study

利用[(18)F]AlF-NOTA-FAPI-04 PET/CT对系统性硬化症中的成纤维细胞活化进行分子成像:一项前瞻性队列研究

Zhao, Meixin; Wei, Hui; Wang, Meng; Wang, Zeyang; Li, Xinwei; Li, Hui; Zhang, Annan; Xue, Song; Hacker, Marcus; Zhang, Weifang; Mu, Rong; Li, Xiang

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

结外弥漫性大B细胞淋巴瘤:多中心EXPECT研究的临床和分子见解及生存结果

Chen, Si-Yuan; Xu, Peng-Peng; Feng, Ru; Cui, Guo-Hui; Wang, Li; Cheng, Shu; Mu, Rong-Ji; Zhang, Hui-Lai; Wei, Xiao-Lei; Song, Yong-Ping; Ding, Kai-Yang; Dong, Li-Hua; Zhu, Zun-Min; Yang, Shen-Miao; Wang, Xin; Liu, Ting-Bo; Hu, Jian-Da; Zheng, Xiao-Yun; Bai, Ou; Xu, Jing-Yan; Huang, Liang; Sang, Wei; Shi, Ke-Qian; Zhou, Fan; Li, Fei; Liang, Ai-Bin; Zhou, Hui; Hao, Si-Guo; Huang, Hong-Hui; Xu, Bin; Qian, Wen-Bin; Li, Cai-Xia; Li, Zhi-Ming; Wu, Chong-Yang; Wang, Xiao-Bo; Shi, Wen-Yu; Wang, Shu-Ye; Tian, Yu-Yang; Zhang, Xi; Zhou, Ke-Shu; Cui, Li-Juan; Liu, Hui; Tan, Huo; Leng, Qing; Zhao, Dong-Lu; Niu, Ting; Zhao, Wei-Li

A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma.

一项针对新发弥漫性大B细胞淋巴瘤的 2 期研究,评估 zanubrutinib 与利妥昔单抗和来那度胺联合用药的疗效。

Xu Peng-Peng, Zhu Yue, Shi Zi-Yang, Wang Li, Cheng Shu, Qian Ying, Zhao Yan, He Yang, Yi Hong-Mei, Ou-Yang Bin-Shen, Jiang Xu-Feng, Li Biao, Song Qi, Mu Rong-Ji, Zhao Wei-Li

Poly-β-D-(1,6)-N-acetyl-glucosamine (PNAG) glycan vaccines with broad spectrum neutralizing activities

具有广谱中和活性的聚β-D-(1,6)-N-乙酰氨基葡萄糖 (PNAG) 糖疫苗

Liao, Kuo-Shiang; Kao, Mu-Rong; Ma, Tzu-Hsuan; Hsu, Mei-Hua; Chen, Tzu-Yin; Imre, Balázs; Harris, Philip J; Shie, Jiun-Jie; Chiu, Cheng-Hsun; Wu, Chung-Yi; Hsieh, Yves S Y

Integration of gene mutations in risk prognostication for watch-and-wait follicular lymphoma patients initiating first-line treatment

将基因突变整合到观察等待策略下滤泡性淋巴瘤患者一线治疗的风险预后评估中

Xu, Tian-Yuan; Mu, Rong-Ji; Zhang, Hui-Lai; Xu, Bing; Li, Rong; Wang, Nan; Sun, Rui; Li, Rui-Chi; Fu, Di; Wang, Xian-Huo; Li, Zhi-Feng; Zhao, Yan; Xu, Peng-Peng; Cheng, Shu; Wang, Li; Tang, Wei; Zheng, Zhong; Zhao, Wei-Li

Investigating the origins of the mutational signatures in cancer

研究癌症突变特征的起源

Boysen, Gunnar; Alexandrov, Ludmil B; Rahbari, Raheleh; Nookaew, Intawat; Ussery, Dave; Chao, Mu-Rong; Hu, Chiung-Wen; Cooke, Marcus S

Robust generation of clinically applicable human pluripotent stem cells from peripheral blood by chemical reprogramming

利用化学重编程技术从外周血中高效生成具有临床应用价值的人类多能干细胞

Fu, Xiaodi; Peng, Fangqi; Cai, Ruyi; Mao, Jingping; Liu, Tianxing; Dong, Yingshuai; Cheng, Ruoqi; Yang, Zhihan; Chen, Guanxian; Li, Cheng; Mu, Rong; Cheng, Lin; Wang, Yanglu; Guan, Jingyang; Deng, Hongkui

A prognostic index integrating deep learning baseline PET/CT biomarkers and multi-omics profiling in diffuse large B cell lymphoma

弥漫性大B细胞淋巴瘤预后指数:整合深度学习基线PET/CT生物标志物和多组学分析

Wang, Yue; Wang, Xue; Huang, Xin-Yun; Jing, Hong-Mei; Jiang, Song-Fu; Li, He; Mu, Rong-Ji; Shi, Qing; Fu, Di; Li, Zhuo-Han; Yi, Hong-Mei; Ouyang, Bin-Shen; Li, Biao; Yan, Fu-Hua; Niu, Ting; Cheng, Shu; Wang, Li; Wen, Ning; Xu, Peng-Peng; Zhao, Wei-Li

Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology.

利用数字病理学对弥漫性大B细胞淋巴瘤的微环境进行实用分类

Wang Yu-Qing, Wang Shuo, Yi Hong-Mei, Qian Ying, Wang Yue, Xu Hai-Min, Xu-Monette Zijun Y, Au Kelly, Tian Shuang, Dong Yan, Zhao Jing, Fu Di, Mu Rong-Ji, Wang Shu-Ye, Wang Li, Young Ken H, Xu Peng-Peng, Zhao Wei-Li

Shared immunological pathways in rheumatoid arthritis-related interstitial lung disease

类风湿性关节炎相关间质性肺病的共同免疫通路

Xu, Jingyi; Li, Changhong; Zhao, Jinxia; Mu, Rong